Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Fupin Hu"'
Autor:
Yan Guo, Bo Zheng, Ziyong Sun, Yunsong Yu, Ying Zhu, Zhongju Chen, Yingchun Xu, Ge Zhang, Wei Kang, Jingjia Zhang, Peiyao Jia, Jie Lin, Simeng Duan, Haixia Li, Qiwen Yang, Tong Wang, Xue Li, Yuan Lv, Ran Jing, Yun Li, Fupin Hu, Minggui Wang
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:2593-2599
Objectives To establish the epidemiological cut-off values (ECOFFs) for cefoselis against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosa. Methods We collected 2288 non-repetitive clinical i
Autor:
Yi-Wei Tang, Xiaohua Qin, Min Li, Yunsong Yu, Haomin Zhang, Fred C. Tenover, Peiyao Jia, Fupin Hu, Qiwen Yang, Xi Jin, Shi Wu
Publikováno v:
The Journal of Molecular Diagnostics. 23:111-119
Rapid detection of carbapenemase-producing organisms is clinically desirable for hospital infection control and antibiotic stewardship. In this multicenter study, the Xpert Carba-R assay was evaluated for detection of the five carbapenemase genes (bl
Autor:
Wenxiang Chen, Chuan-Fan Ding, Fupin Hu, Bin Feng, Huayan Yang, Jian He, Shaoning Yu, Haimei Shi, Fuxing Xu
Publikováno v:
Analytica Chimica Acta. 1111:75-82
MALDI-TOF MS is well-recognized for microbial identification and widely used in research and clinical fields due to its specificity, speed of analysis, and low cost of consumables. However, the classification or identification accuracy is poor for E.
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 38:2275-2281
The aim of this study is to investigate the antimicrobial susceptibility of strains isolated from the major hospitals in China. A total of 44 teaching hospitals were involved. Antimicrobial susceptibility testing was conducted by Kirby-Bauer automate
Publikováno v:
Clinical Infectious Diseases. 67:S128-S134
The bacterial resistance surveillance system is relatively well established at the national, provincial, and hospital levels in China. Two representative national surveillance networks for bacterial resistance are the China Antimicrobial Resistance S
Autor:
Shi Wu, Dandan Yin, Yonggui Zheng, Yang Yang, Li Ding, Fupin Hu, Demei Zhu, Renru Han, Yan Guo
Sitafloxacin is one of the newer generation fluoroquinolones. Considering the ever-changing antimicrobial resistance, it is necessary to monitor the activities of sitafloxacin against recent pathogenic isolates. Therefore, we determined the minimum i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2acdfe446ded30a8d4d6d907e761ab78
https://doi.org/10.21203/rs.3.rs-173942/v1
https://doi.org/10.21203/rs.3.rs-173942/v1
Publikováno v:
Antimicrobial Agents and Chemotherapy. 65
This study evaluated the in vitro activity of cefepime-zidebactam in comparison with that of ceftazidime-avibactam and other comparators against clinically significant Gram-negative bacillus isolates. A total of 3,400 nonduplicate Gram-negative clini
Background: To understand the clinical characteristics of vancomycin-resistant Enterococcus (VRE) infection.Methods: The clinical characteristics of patients with VRE infection, members of CHINET Bacterial Drug Resistance Monitoring Network, in 2016,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::958f7863cff9d4337e68f568134f2e29
https://doi.org/10.21203/rs.3.rs-110647/v1
https://doi.org/10.21203/rs.3.rs-110647/v1
Publikováno v:
Antimicrobial Agents and Chemotherapy. 64
The in vitro activities of ceftaroline and tedizolid were compared against Staphylococcus aureus , Enterococcus faecalis , and Enterococcus faecium clinical isolates collected from the China Antimicrobial Surveillance Network. Ceftaroline demonstrate
Publikováno v:
Frontiers in Microbiology
Frontiers in Microbiology, Vol 11 (2020)
Frontiers in Microbiology, Vol 11 (2020)
Purpose: Lefamulin is a novel antibiotic approved by the U.S. Food and Drug Administration in 2019 for the treatment of community-acquired bacterial pneumonia (CABP). In this study we evaluated the in vitro antimicrobial activity of lefamulin in orde